Transcriptomic and phenotypic characterization of a Bacillus subtilis strain without extracytoplasmic function σ factors.
Bacillus subtilis encodes seven extracytoplasmic function (ECF) σ factors. Three (σ(M), σ(W), and σ(X)) mediate responses to cell envelope-active antibiotics. The functions of σ(V), σ(Y), σ(Z), and σ(YlaC) remain largely unknown, and strong inducers of these σ factors and their regulons have yet to be defined. Here, we define transcriptomic and phenotypic differences under nonstress conditions between a strain carrying deletions in all seven ECF σ factor genes (the Δ7ECF mutant), a ΔMWX triple mutant, and the parental 168 strain. Our results identify >80 genes as at least partially dependent on ECF σ factors, and as expected, most of these are dependent on σ(M), σ(W), or σ(X), which are active at a significant basal level during growth. Several genes, including the eps operon encoding enzymes for exopolysaccharide (EPS) production, were decreased in expression in the Δ7ECF mutant but affected less in the ΔMWX mutant. Consistent with this observation, the Δ7ECF mutant (but not the ΔMWX mutant) showed reduced biofilm formation. Extending previous observations, we also note that the ΔMWX mutant is sensitive to a variety of antibiotics and the Δ7ECF mutant is either as sensitive as, or slightly more sensitive than, the ΔMWX strain to these stressors. These findings emphasize the overlapping nature of the seven ECF σ factor regulons in B. subtilis, confirm that three of these (σ(M), σ(W), and σ(X)) play the dominant role in conferring intrinsic resistance to antibiotics, and provide initial insights into the roles of the remaining ECF σ factors.
Luo
Yun
Y
Department of Microbiology, 370 Wing Hall, Cornell University, Ithaca, NY 14853, USA.
Asai
Kei
K
Sadaie
Yoshito
Y
Helmann
John D
JD
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001398:Aztreonam / Q000494:pharmacology; D001412:Bacillus subtilis / Q000145:classification* / Q000235:genetics* / Q000378:metabolism; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D018441:Biofilms; D002444:Cefuroxime / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D020869:Gene Expression Profiling; D015964:Gene Expression Regulation, Bacterial / Q000502:physiology; D009154:Mutation; D020411:Oligonucleotide Array Sequence Analysis; D010641:Phenotype; D011401:Promoter Regions, Genetic; D012808:Sigma Factor / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D012808:Sigma Factor; D001398:Aztreonam; D002444:Cefuroxime
Microbiology (Reading). 2005 May;151(Pt 5):1577-1592
15870467
Mol Microbiol. 2006 May;60(3):765-82
16629676
Yeast. 1996 Mar 15;12(3):259-65
8904338
J Bacteriol. 2003 Aug;185(16):4883-90
12897008
J Biol Chem. 2004 Sep 17;279(38):39340-7
15247225
Environ Microbiol. 2007 Dec;9(12):2933-44
17991024
J Bacteriol. 2005 May;187(9):2948-56
15838020
Genome Res. 2001 Jul;11(7):1246-55
11435407
Mol Microbiol. 2001 Dec;42(5):1199-209
11886552
Adv Microb Physiol. 2002;46:47-110
12073657
Science. 2008 Jun 20;320(5883):1636-8
18566286
FEBS Lett. 1993 Dec 13;335(3):319-26
8262178
Appl Environ Microbiol. 2005 Jan;71(1):39-45
15640167
Antimicrob Agents Chemother. 1982 Jun;21(6):950-6
6180685
J Bacteriol. 2004 Feb;186(4):1136-46
14762009
Mol Microbiol. 2008 Feb;67(4):830-48
18179421
Mol Microbiol. 1999 Apr;32(1):41-50
10216858
J Bacteriol. 2002 Nov;184(22):6123-9
12399481
J Bacteriol. 2007 Jun;189(12):4534-8
17434969
Mol Microbiol. 2002 Sep;45(5):1267-76
12207695
J Bacteriol. 2003 Jun;185(12):3491-8
12775685
Mol Microbiol. 2003 Dec;50(5):1591-604
14651641
J Biochem. 2003 Dec;134(6):935-46
14769884
J Bacteriol. 1998 Apr;180(8):2194-200
9555904
J Mol Biol. 1998 May 29;279(1):165-73
9636707
Toxicol Appl Pharmacol. 2006 Nov 15;217(1):100-6
16978678
Mol Microbiol. 2001 Jul;41(1):59-71
11454200
Microbiology (Reading). 2004 Mar;150(Pt 3):591-599
14993308
Microbiology (Reading). 2009 Jun;155(Pt 6):1758-1775
19383706
Mol Microbiol. 2007 Jun;64(6):1515-28
17511812
Genes Genet Syst. 2005 Dec;80(6):385-93
16501307
J Bacteriol. 2009 Nov;191(22):6822-32
19767430
Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12554-9
16105942
FEMS Microbiol Lett. 2005 Dec 15;253(2):221-9
16274938
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
9843981
J Biol Chem. 1998 Sep 4;273(36):23134-42
9722542
Mol Microbiol. 2002 Sep;45(5):1379-88
12207704
J Mol Biol. 2002 Feb 22;316(3):443-57
11866510
Mol Microbiol. 2003 Jul;49(1):157-65
12823818
J Bacteriol. 2009 Apr;191(8):2423-30
19201793
J Bacteriol. 2008 Apr;190(7):2633-6
18223082
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2230-4
20080671
J Bacteriol. 2009 Aug;191(15):4951-8
19465659
Mol Microbiol. 2006 Feb;59(4):1229-38
16430696
J Bacteriol. 2001 Apr;183(7):2380-3
11244082
J Bacteriol. 2007 Nov;189(21):7720-32
17720793
J Bacteriol. 2007 Oct;189(19):6919-27
17675383
Antimicrob Agents Chemother. 2009 Apr;53(4):1598-609
19164152
FEMS Microbiol Lett. 2003 Mar 14;220(1):155-60
12644242
J Bacteriol. 2006 Jan;188(2):687-93
16385058